Encompass Health Corporation Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate
Encompass Health Corporation (EHC) reported Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate of 2.10% for the 12-month period ending 2015-12-31, per its 10-K filed 2016-02-25.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Fair Value Assumptions and Methodology
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate · last filed 2016-02-25
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2015 was 2.10%, a 0.00% change from fiscal 2014.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2014 was 2.10%.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2013 was 0.00%.
- Encompass Health Corporation share-based compensation arrangement by share-based payment award, fair value assumptions, expected dividend rate for fiscal 2012 was 0.00%.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate 12 month |
|---|---|
| 2015-12-31 | 2.10% 10-K · filed 2016-02-25 |
| 2014-12-31 | 2.10% 10-K · filed 2016-02-25 |
| 2013-12-31 | 0.00% 10-K · filed 2016-02-25 |
| 2012-12-31 | 0.00% 10-K · filed 2015-03-02 |
| 2011-12-31 | 0.00% 10-K · filed 2014-02-20 |
| 2010-12-31 | 0.00% 10-K · filed 2013-02-19 |
| 2009-12-31 | 0.00% 8-K · filed 2012-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Pediatrix Medical Group, Inc. (MD) | United States | $2.084B | 11.76 |